🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Multicenter Italian Cohort Study on Tuberculosis in Pediatric Age

Recruitingn/aAges 1 Week - 18 YearsAllMeyer Children's Hospital IRCCS
NCT06289660 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

According to the WHO report of 2021, approximately 10 million new cases were reported in 2020, of which 1 million occurred in the pediatric population. However, epidemiological data available on tuberculosis (TB) in pediatric age are extremely limited due to diagnostic challenges in this patient category. Furthermore, children are almost never included in national surveillance systems due to the lack of connections between individual pediatricians, pediatric hospitals, and national surveillance programs. It is therefore reasonable to assume that the disease may be significantly underestimated both in Italy and worldwide.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Pediatric patients (0-18 years old) at the time of the initial observation * Patients affected by active and latent TB, as defined by the criteria of the World Health Organization * Patients exposed to TB who are found to be non-infected at the end of the window period * Informed consent signed by parents/legal guardian or by the patient who has reached the legal age of consent, assent of the minor Exclusion Criteria: * None
💊

What it tests

  • Not listed
📍

Where

17 sites
Meyer Children's Hospital IRCCS
Florence, Italy
Ospedale Pediatrico Giovanni XXIII
Bari, Italy
Ospedale di Belluno
Belluno, Italy
Università di Bologna
Bologna, Italy
IRCCS Istituto Giannina Gaslini
Genova, Italy
Fondazione IRCCS Ca' Granda, Ospedale Maggiore, Policlinico
Milan, Italy
Ospedale Luigi Sacco
Milan, Italy
Policlinico di Modena
Modena, Italy

…and 9 more on ClinicalTrials.gov.

🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy